← SynDRA
EDARAVONE
SynDRA canonical compound SYN0002112 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | BCL2 |
| Mechanism of action | nootropic agent |
| Indication | stroke |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- BCL2 REGULATOR (UPREGULATOR)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- UGT1A9
- ACHE
- NT5E
- MT-CO1
- MT-CO2
- NFE2L2
- NPY1R
- NPY2R
- NR3C1
- OPRD1
- MMP1
- OPRK1
- OPRM1
- PDE3A
- PDE4A
- PDE5A
- MMP9
- MC5R
- POLI
- MC4R
- MC3R
- MAPT
- MAPK3
- MAPK14
- MAPK1
- MAOB
- MAOA
- LCK
- KMT2A
- KDR
- KDM4E
- KCNH2
- IDH1
- PGR
- PPARG
- HTR2C
- PPP3CA
- VDR
- UGT2B7
- UGT2B4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACES
- ADCY9
- TYDP2
- TLR3
- TERA
- SYK
- SENP8
- SAE1
- ROCK2
- PSIP1
- PLCG1
- PADI4
- MBD2
- KSYK
- IP6K1
- GSTO1
- ESRRA
- CP3A7
- CP3A4
- CP2D6
- CP2CJ
- CP2C9
- CP1A2
- APAF
- AHR
- UBA2
Drug classes
- Antioxidants
- Central Nervous System Agents
- Free Radical Scavengers
- Neuroprotective Agents
- Protective Agents
- nootropic agent
ATC classes
- N07X · OTHER NERVOUS SYSTEM DRUGS
Cross-references
Synonyms
- RADICAVA
- RADICAVA ORS
- Radicava
- radicava
- edarabone
- methylphenylpyrazolone
- norantipyrine
- norphenazone
- radicut
- Edaravona
- Norphenazone
- C.i. developer 1
- Colorex pmp
- Developer z
- Jarocol pmp
- Phenyl methyl pyrazolone
- MCI-186
- NSC-12
- NSC-26139
- NSC-2629
- Radicava ors
- Radicut
- Antipyrine related compound a
- MCI 186
- Edarabone
- Methylphenylpyrazolone
- Monopyrazolone
- Norantipyrine
- Phenylmethylpyrazolone
- Developer Z
- Edaravone [INN]
- CDS1_000986
- CI Developer 1
- IN1263
- M0687
- Edaravone(jan)
- Radicut (TN)
Reported adverse events
- Dermatitis
- Eczema
- Gait disturbance
- Glycosuria
- Headache
- Hypersensitivity
- Respiratory failure
- Contusion
- Tinea infection
Look up EDARAVONE in the interactive SynDRA portal →